Xenon (XENE) Ownership - Who Owns Xenon?

469 Followers

Xenon (XENE) Ownership Overview

0.13% Insiders

28.19% Mutual Funds

51.33% Other Institutional Investors

5.99% ETFs

14.36% Public Companies and

Individual Investors

The ownership structure of Xenon (XENE) stock is a mix of institutional, retail, and individual investors. Approximately 85.51% of the company’s stock is owned by Institutional Investors, 0.13% is owned by Insiders, and 14.36% is owned by Public Companies and Individual Investors.

The ownership structure of Xenon (XENE) stock is a mix of institutional, retail, and individual investors. Approximately 79.52% of the company’s stock is owned by Institutional Investors, 0.13% is owned by Insiders, and 5.99% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Jun 06, 2025	Steven Gannon	xxxxxxxxxxxxx	$91

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Driehaus Capital Management Llc	xxxxxxxxxxxxx	$261189622
Mar 31, 2024	Woodline Partners Lp	xxxxxxxxxxxxx	$8740061
Mar 31, 2024	Entrypoint Capital, Llc	xxxxxxxxxxxxx	$513581
Mar 31, 2024	Deerfield Management Company, Lp	xxxxxxxxxxxxx	$93952722

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
Richard Driehaus	4,491,653	Institution	4.65%	268,331,350
	3,971,400	Institution	4.11%	237,251,436
	3,501,794	Institution	3.62%	209,197,174
	2,676,154	Institution	2.77%	159,873,440
	2,120,384	Institution	2.19%	126,671,740
	1,855,964	Institution	1.92%	110,875,289
James E. Flynn	1,615,696	Institution	1.67%	96,521,679
	1,262,485	Institution	1.31%	75,420,854
	1,056,630	Institution	1.09%	63,123,076
	1,056,458	Institution	1.09%	63,112,801

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
3,501,794	Institution	3.62%	209,197,174
2,676,154	Institution	2.77%	159,873,440
2,120,384	Institution	2.19%	126,671,740
1,855,964	Institution	1.92%	110,875,289
1,262,485	Institution	1.31%	75,420,854
1,056,630	Institution	1.09%	63,123,076
1,056,458	Institution	1.09%	63,112,801
961,000	Institution	0.99%	57,410,140
920,237	Institution	0.95%	54,974,958
888,033	Institution	0.92%	53,051,091

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Russell 2000 ETF	2,024,504	Institution	2.09%	112,521,932
iShares Russell 2000 Growth ETF	711,613	Institution	0.74%	39,551,451
iShares Biotechnology ETF	630,809	Institution	0.65%	35,060,364
Vanguard Russell 2000 ETF	444,177	Institution	0.46%	24,309,807
SPDR Portfolio Developed World ex-US ETF	149,012	Institution	0.15%	8,137,545
Fidelity Enhanced Small Cap ETF	142,009	Institution	0.15%	7,755,111
ALPS Medical Breakthroughs ETF	95,954	Institution	0.10%	5,333,123
Vanguard Russell 2000 Growth ETF	81,196	Institution	0.08%	4,443,857
Nuveen ESG Small-Cap ETF	76,043	Institution	0.08%	4,226,470
iShares NASDAQ US Biotechnology UCITS ETF	70,693	Institution	0.07%	3,873,269

FAQ

Who Owns Xenon Pharmaceuticals (XENE)?

According to the latest TipRanks data, approximately 51.33% of the company's stock is held by institutional investors, 0.13% is held by insiders, and 14.36% is held by retail investors.

What percentage of Xenon Pharmaceuticals (XENE) stock is held by institutional investors?

According to the latest TipRanks data, approximately 51.33% of Xenon Pharmaceuticals (XENE) stock is held by institutional investors.

What percentage of Xenon Pharmaceuticals (XENE) stock is held by retail investors?

According to the latest TipRanks data, approximately 14.36% of Xenon Pharmaceuticals (XENE) stock is held by retail investors.

Who owns the most shares of Xenon Pharmaceuticals (XENE)?

Richard Driehaus owns the most shares of Xenon Pharmaceuticals (XENE).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.